The US-based company continues its move away from smoking products with the purchase of drug developer OtiTopic, as part of its Beyond Nicotine initiative.
ERT’s purchase of iCardiac Technologies follows three months after its purchase Biomedical Systems, the additions of which further increase the company’s portfolio of cardiac safety solutions.
Cardiac safety assessment service provider iCardiac Technologies has added respiratory and ePRO services to its offerings through the acquisition of the clinical trials division of nSpire Health.